Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Response to mTOR and PI3K inhibitors in enzalutamide-resistant luminal androgen receptor triple-negative breast cancer patient-derived xenografts.
Theranostics. 2020 Jan 1;10(4):1531-1543. doi: 10.7150/thno.36182. eCollection 2020.
Theranostics. 2020.
PMID: 32042320
Free PMC article.
High in vitro and in vivo synergistic activity between mTORC1 and PLK1 inhibition in adenocarcinoma NSCLC.
Montaudon E, El Botty R, Vacher S, Déas O, Naguez A, Chateau-Joubert S, Treguer D, de Plater L, Zemoura L, Némati F, Nicolas A, Chapelier A, Livartowski A, Cairo S, Daniel C, Brevet M, Marangoni E, Meseure D, Roman-Roman S, Bieche I, Girard N, Decaudin D.
Montaudon E, et al. Among authors: naguez a.
Oncotarget. 2021 Apr 13;12(8):859-872. doi: 10.18632/oncotarget.27930. eCollection 2021 Apr 13.
Oncotarget. 2021.
PMID: 33889306
Free PMC article.
Item in Clipboard
PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma.
de Koning L, Decaudin D, El Botty R, Nicolas A, Carita G, Schuller M, Ouine B, Cartier A, Naguez A, Fleury J, Cooke V, Wylie A, Smith P, Marangoni E, Gentien D, Meseure D, Mariani P, Cassoux N, Piperno-Neumann S, Roman-Roman S, Némati F.
de Koning L, et al. Among authors: naguez a.
Cancers (Basel). 2019 May 29;11(6):751. doi: 10.3390/cancers11060751.
Cancers (Basel). 2019.
PMID: 31146482
Free PMC article.
Item in Clipboard
Selumetinib-based therapy in uveal melanoma patient-derived xenografts.
Decaudin D, El Botty R, Diallo B, Massonnet G, Fleury J, Naguez A, Raymondie C, Davies E, Smith A, Wilson J, Howes C, Smith PD, Cassoux N, Piperno-Neumann S, Roman-Roman S, Némati F.
Decaudin D, et al. Among authors: naguez a.
Oncotarget. 2018 Apr 24;9(31):21674-21686. doi: 10.18632/oncotarget.24670. eCollection 2018 Apr 24.
Oncotarget. 2018.
PMID: 29774094
Free PMC article.
Item in Clipboard
Dramatic In Vivo Efficacy of the EZH2-Inhibitor Tazemetostat in PBRM1-Mutated Human Chordoma Xenograft.
Passeri T, Dahmani A, Masliah-Planchon J, Naguez A, Michou M, El Botty R, Vacher S, Bouarich R, Nicolas A, Polivka M, Franck C, Schnitzler A, Némati F, Roman-Roman S, Bourdeaut F, Adle-Biassette H, Mammar H, Froelich S, Bièche I, Decaudin D.
Passeri T, et al. Among authors: naguez a.
Cancers (Basel). 2022 Mar 14;14(6):1486. doi: 10.3390/cancers14061486.
Cancers (Basel). 2022.
PMID: 35326637
Free PMC article.
Item in Clipboard
Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma.
Decaudin D, Frisch Dit Leitz E, Nemati F, Tarin M, Naguez A, Zerara M, Marande B, Vivet-Noguer R, Halilovic E, Fabre C, Jochemsen A, Roman-Roman S, Alsafadi S.
Decaudin D, et al. Among authors: naguez a.
Eur J Cancer. 2020 Feb;126:93-103. doi: 10.1016/j.ejca.2019.12.012. Epub 2020 Jan 9.
Eur J Cancer. 2020.
PMID: 31927215
Free article.
Item in Clipboard
HIF-1α triggers ER stress and CHOP-mediated apoptosis in alveolar epithelial cells, a key event in pulmonary fibrosis.
Delbrel E, Soumare A, Naguez A, Label R, Bernard O, Bruhat A, Fafournoux P, Tremblais G, Marchant D, Gille T, Bernaudin JF, Callard P, Kambouchner M, Martinod E, Valeyre D, Uzunhan Y, Planès C, Boncoeur E.
Delbrel E, et al. Among authors: naguez a.
Sci Rep. 2018 Dec 18;8(1):17939. doi: 10.1038/s41598-018-36063-2.
Sci Rep. 2018.
PMID: 30560874
Free PMC article.
Item in Clipboard
Corrigendum to "Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma" [Eur J Cancer 126 (2020) 93-103].
Decaudin D, Dit Leitz EF, Nemati F, Tarin M, Naguez A, Zerara M, Marande B, Vivet-Noguer R, Halilovic E, Fabre C, Jochemsen A, Roman-Roman S, Alsafadi S.
Decaudin D, et al. Among authors: naguez a.
Eur J Cancer. 2023 May;184:199. doi: 10.1016/j.ejca.2023.02.004. Epub 2023 Mar 1.
Eur J Cancer. 2023.
PMID: 36868971
Free article.
No abstract available.
Item in Clipboard
Cite
Cite